haemophilia (Factor VIII deficiency) diagnosed when 1 year old. Since that time he had received a total of 21 intravenous injections of cryoprecipitate.
In December 1971 he was seen with a haemarthrosis of the left knee and multiple ecchymoses over both legs. It was decided to give cryoprecipitate, which was drawn into a 30 ml syringe and given intravenously. After 10 ml had been given, the patient started to cough, and after a further 5 ml, he became pale, sweaty, and shocked, and stated that he thought he was going to die. His peripheral pulses were impalpable and the blood pressure could not be recorded. Chlorpheniramine 10 mg and hydrocortisone 100 mg were given intravenously with some improvement, so that his blood pressure was then recorded. His respirations were rapid with marked recession and central cyanosis. He to bee stings, it seems unlikely that donor L's serum would contain sufficient foreign protein 9 weeks after a bee sting for this reaction. There was also no demonstrable incompatibility between the serum from donor L and the patient by immunodiffusion.
Although the intravascular haemolysis could well have been due to a reaction between transfused anti-A from donor P and the patient's A2B red cells, severe anaphylaxis and pulmonary oedema are not characteristic ofABO incompatibility. The present case is, however, very similar to that described by Mollison (1967) The anaphylactic shock in our patient was similar to that produced sometimes with y-globulin (Barandun et al., 1962) , but this reaction would not be responsible for the intravascular haemolysis. Severe reactions from transfused plasma have been described due to IgA incompatibility (Vyas, Perkins, and Fudenberg, 1968; Schmidt, Taswell, and Gleich, 1969; Miller et al., 1970) and Gm incompatibility (Fudenberg et al., 1964; Fischer, 1965; Jensen, Gurtler, and Bruusgaard, 1968; Prentice et al., 1971) , but both these causes were eliminated here. Eisen (1965) found levels of kinin-forming activity and of C'l-esterase in Factor VIII-rich fractions of fresh plasma and the quantity was sufficient to produce side effects during transfusions. All tested batches had a similar potency for both these enzymes, so he suggested that the factor determining whether the patient has a reaction or not is the capacity of the patient's blood to inactivate these enzymes and the rate of inactivation is dependent upon the speed of the injection. Maycock et al., (1963) have shown that reactions are less frequent when the injection is given slowly. We have not investigated this mechanism fully, but it is interesting to note that the level of C'l-esterase inhibitor in the cryoprecipitate used was found to be at the upper limit of the normal range.
Conclusion All physicians treating patients suffering from haemophilia should be aware that severe reactions may occur and be prepared for them, and perhaps be less enthusiastic in using cryoprecipitate for relatively trivial bleeding than in the past. It appears that the haemoglobinuria and bilirubinaemia in our patient might have been due to the high titre anti-A in spite of it being mixed with group AB donor plasma. The anaphylactic shock might have been due to the rapid injection allowing the enzymes to form kinins in the patient. It 
